Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 06/13/2016 - 04/20/2019

Members can access this product for only $25. Log in or Join now!

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

There are a lack of studies comparing the differences among second generation long-acting injectables (SGA LAIs) and limited guidelines to help clinicians choose the most appropriate agents for each individual, particularly given the availability of newer agents. Also insufficient are epidemiological data on re-hospitalization and adherence rates amongst the different SGA LAIs. Barriers, including cost and acceptance, may further limit the use of these agents and it is important that strategies to overcome these barriers be identified.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Leigh Anne Nelson, PharmD, BCPP

View biographical information and disclosures

Learning Objectives

  1. Discuss the benefits of utilizing long-acting injectables (LAI) antipsychotic medications.
  2. Outline the advantages of LAI over oral formulations in first episode psychosis. 
  3. Identify key factors to consider when selecting a second generation antipsychotic (SGA) LAI for an individual patient.
  4. Describe barriers to using SGA LAI therapy and potential strategies to overcoming these barriers in clinical practice.

Continuing Education Credit and Disclosures

Activity Dates: 06/13/2016 - 04/20/2019
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-16-024-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.1 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-16-024-H01-P (1.0 contact hours).